The Prostate Cancer Research Foundation of Canada Report issue

Foundation Phase 2

Organization Overview

First Clinical Trial
2003
NCT00156884
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2008

Timeline

NOW
  • Now